Stock market announcement archive

Subscriptions by primary insiders and employees under Lifecare Employee Share Purchase Program – Registration of new share capital

July 26, 2022
Bergen, Norway 26.7.22Reference is made to Stock Exchange Announcement 15 July 2022 regardingsubscriptions under Lifecare Employee Share Purchase Program and the share issueresolved by Lifecare's Board of Directors. Employees in the Lifecare Group have been allocated in total 124 719 shares, ofwhich primary insiders Joacim Holter (Lifecare CEO) and Prof. Andreas Pfützner(Lifecare CSO) both have […]
Read more

Lifecare Employee Share Purchase Program – Subscriptions by Primary Insiders – Increase of share capital

July 15, 2022
Bergen, Norway 15.7.22Reference is made to Stock Exchange Announcement 23 May 2022 regarding theestablishment of Lifecare Group incentive program. All employees in the Lifecare Group have been invited to participate inLifecares Employee Share Purchase Program 2022 and individually subscribe for upto 20 000 shares with a 25% discount off the volume weighted average share price(VWAP) […]
Read more

LIFE: Mandatory notification of trade

June 1, 2022
Bergen, Norway 1 June 2022Primary insider Joacim Holter has bought 25 000 shares at an average price of3,01 in Lifecare AS. Joacim Holter currently holds 272.997 shares in Lifecare AS, and after thetrade, Joacim Holter will hold a total of 297 997 shares in Lifecare AS. JoacimHolter also owns shares in Lifecare through his fully […]
Read more

Issuance of new shares to primary insider – in accordance with share purchase agreement prev. announced

April 20, 2022
Bergen, Norway 20 April 2022Islay Venture GmbH ("Islay), a company closely related to Lifecare's ChiefScientific Officer and primary insider Prof. Dr. Dr. med Andreas Pfützner, willsubscribe 1.756.876 new shares in Lifecare AS, as part of the previously agreedconsideration from Lifecare AS to acquire Lifecare Laboratories GmbH (formelynamed Pfützner Science and Health GmbH). The acquisition and […]
Read more

Notification of trade – primary insider

October 5, 2021
Bergen, Norway 05.10.2021Reference is made to the announcement published on 5 October 2021 by Lifecare AS(the "Company") regarding the completion of a private placement (the "PrivatePlacement").The following primary insider has been allocated shares in the PrivatePlacement: Hereid Invest AS, a company wholly owned by the Company's investorrelations and controller Kine Hereid, has been allocated 117,647 […]
Read more

LIFE: Exercise of options and lock up agreement with primary insider

September 14, 2021
Bergen, Norway 14.09.21Lifecare's Chief Scientific Officer and primary insider Prof. Dr. Dr. medAndreas Pfützner, has notified Lifecare AS that his company Islay Venture GmbH("Islay) will exercise share options of 195,498. The exercised share optionshave each a strike price of NOK 0.40 and were set to expire on 1 October 2021.Islay currently holds 648,125 shares in […]
Read more

LIFE: Notification of Extraordinary General Meeting regarding a potential private placement of new shares and information regarding acquisition of laboratory

August 27, 2021
Bergen, Norway 27.08.21NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY ORINDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THEUNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION ORDISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFEROF ANY OF THE SECURITIES DESCRIBED HEREIN.SummaryToday the […]
Read more

LIFE: The European Patent Office grants new Lifecare patent

August 3, 2021
Bergen, Norway 03.08.21The European Patent Office (EPO) has as expected decided to grant Lifecare a newpatent for an updated sensor measuring system. The now approved patent expandsLifecare's protection in time and scope. As announced in Lifecare's press release 25.03.21, the EPO by then intended togrant this patent, about an "interstitial fluid osmotic pressure measuringdevice system […]
Read more

LIFE: Lifecare AS acquires Cantimed UG and broadens its biosensing capabilities

June 24, 2021
Bergen, Norway 24.06.21Lifecare AS has acquired 100% ownership of the German company Cantimed UG,following a share purchase agreement with Nanoscale Systems Nanoss GmbH. The transaction includes a license ensuring LifecareŽs access to the patentedNano3DSense technology in the medical field. This implies a continuation ofLifecare's license covering the field of diabetes originally established in 2018- and […]
Read more

LIFE: Lifecare well protected in the event of Digid bankrupcy

April 4, 2021
4. April 2021, Bergen - Digital Diagnostics AG's (Digid) management has filedfor bankruptcy at the district court of Mainz. The filing was delivered withoutany prior information to or discussion with the Digid Supervisory board. The joint venture agreement regarding Digid provides protection of Lifecare'sinterests, including Lifecare IP rights, in the event of a bankruptcy. "All […]
Read more